Sunshine Biopharma, Inc. (SBFM)
0.243
+0.01
(+2.84%)
USD |
NASDAQ |
Oct 14, 16:00
0.2292
-0.01
(-5.68%)
After-Hours: 20:00
Sunshine Biopharma Price : 0.243 for Oct. 14, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | 0.235 | 0.2478 | 0.2121 | 0.243 | 1.738M |
| Oct 13, 2026 | 0.2891 | 0.2987 | 0.23 | 0.2363 | 4.851M |
| Oct 12, 2026 | 0.3094 | 0.3295 | 0.2812 | 0.302 | 2.471M |
| Oct 09, 2026 | 0.4012 | 0.4022 | 0.3312 | 0.3378 | 6.954M |
| Oct 08, 2026 | 0.4708 | 0.4708 | 0.3802 | 0.43 | 118.47M |
| Oct 07, 2026 | 0.4095 | 1.56 | 0.40 | 0.70 | 177.96M |
| Oct 06, 2026 | 0.4318 | 0.434 | 0.3564 | 0.3979 | 4.525M |
| Oct 05, 2026 | 0.485 | 0.4999 | 0.4117 | 0.4201 | 2.130M |
| Oct 02, 2026 | 0.71 | 0.7488 | 0.6665 | 0.6665 | 149376.0 |
| Oct 01, 2026 | 0.78 | 0.78 | 0.6715 | 0.6876 | 133891.0 |
| Sep 30, 2026 | 0.8053 | 0.8336 | 0.773 | 0.773 | 47517.00 |
| Sep 29, 2026 | 0.8102 | 0.8122 | 0.7779 | 0.7874 | 38037.00 |
| Sep 28, 2026 | 0.8423 | 0.85 | 0.8169 | 0.8179 | 38068.00 |
| Sep 25, 2026 | 0.838 | 0.8598 | 0.8014 | 0.8426 | 131684.0 |
| Sep 24, 2026 | 0.8679 | 0.8801 | 0.7779 | 0.8001 | 190645.0 |
| Sep 23, 2026 | 0.90 | 0.9282 | 0.87 | 0.8758 | 94689.00 |
| Sep 22, 2026 | 0.9271 | 0.9599 | 0.86 | 0.9063 | 406962.0 |
| Sep 21, 2026 | 0.89 | 0.97 | 0.86 | 0.9091 | 220386.0 |
| Sep 18, 2026 | 0.82 | 0.8999 | 0.82 | 0.8998 | 157772.0 |
| Sep 17, 2026 | 1.01 | 1.01 | 0.8411 | 0.8411 | 355421.0 |
| Sep 16, 2026 | 1.022 | 1.058 | 1.015 | 1.03 | 126518.0 |
| Sep 15, 2026 | 1.068 | 1.068 | 1.025 | 1.03 | 92729.00 |
| Sep 14, 2026 | 1.05 | 1.08 | 1.05 | 1.07 | 63273.00 |
| Sep 11, 2026 | 1.10 | 1.115 | 1.05 | 1.06 | 99918.00 |
| Sep 10, 2026 | 1.14 | 1.14 | 1.08 | 1.08 | 144020.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.25 |
| Alnylam Pharmaceuticals, Inc. | 224.47 |
| Anika Therapeutics, Inc. | 20.25 |
| Savara, Inc. | 4.76 |
| Vericel Corp. | 40.25 |
Price Related Metrics
| PS Ratio | 0.0048 |
| Price to Book Value | 0.0211 |
| Earnings Yield | -4.21K% |
| Market Cap | 0.5804M |